The QualityStocks Daily Stock List
- Peekaboo Beans, Inc. (PBBSF)
- Sunshine Biopharma, Inc. (SBFM)
- Edgewater Wireless Systems, Inc. (KPIFF)
- Fission Uranium Corp. (FCUUF)
- Real Goods Solar, Inc. (RGSE)
- Repro Med Systems, Inc. (REPR)
- Spearmint Resources, Inc. (SPMTF)
- Cannabis Sativa, Inc. (CBDS)
- Mobetize Corp. (MPAY)
- Viking Energy Group, Inc. (VKIN)
- Grow Solutions Holdings, Inc. (GRSO)
- Inspyr Therapeutics, Inc. (NSPX)
- TimefireVR, Inc. (TFVR)
- Innovative Designs, Inc. (IVDN)
Peekaboo Beans, Inc. (PBBSF)
Small Cap Power, Pinnacle Digest, Morningstar, Barchart, Investorx, Investors Hangout, Dividend Investor, Trading View, Stockwatch, OTC Markets, Wallet Investor, and Stockhouse reported earlier on Peekaboo Beans, Inc. (PBBSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Peekaboo Beans, Inc. designs, manufactures, and sells children playwear apparel in the United States and Canada. The Company focuses on ethically produced, environmentally responsible clothes that are intentionally designed to inspire play. It engages sellers by way of social platforms, including Instagram and Facebook, and also online retailers, to maximize revenue and build brand loyalty. Peekaboo Beans distributes its products via a direct-sales channel of independent sales representatives or stylists; and online. Peekaboo Beans has its corporate headquarters in Vancouver, British Columbia.
The Company sells dresses and tunics, tees and tanks, hoodies, leggings and pants, skirts and shorts, and jackets and coats for girls. It also sells bean playsuits, tees and tanks, jackets and coats, and leggings and pants. Furthermore, Peekaboo Beans sells tees and tanks, hoodies, pants and shorts, jackets and coats and underwear for boys. The Company also provides accessories, including backpacks, lunch bags, snack bags, water bottles, as well as baby accessories.
Peekaboo Beans styles are high-quality oeko-tex standard 100. This enables parents to make meaningful choices with their money by purchasing products that last longer and are passed along from child to child. As a result, this decreases wasteful spending. The Company produces its products to ensure sustainability. Its intention is to keep its clothing out of landfills for as long as possible, and as such its clothes are made to be durable.
Today, Peekaboo Beans announced that Ms. Tamara Mimran, Merchandise Director of the Mimran Group, Inc., has been appointed to the Board of Directors of Peekaboo Beans. Ms. Mimran (together with her father and brother) manages more than ten different licenses internationally for the Alfred Sung brand.
Traci Costa, Founder and Chief Executive Officer of Peekaboo Beans, said, "We are very excited to welcome Tamara to the team. The Mimran family has an iconic legacy in Canadian fashion and Tamara's experience with developing brands internationally will be of great use to us, as we continue to expand our reach to loyal customers all across North America."
Peekaboo Beans, Inc. (PBBSF), closed Tuesday's trading session at $0.059, even for the day, on 15,000 volume. The average volume for the last 3 months is 4,797 and the stock's 52-week low/high is $0.059/$0.200000002.
Sunshine Biopharma, Inc. (SBFM)
Stockwatch, Investing.com, Real Investment Advice, Trading View, Market Screener, GuruFocus, Stockopedia, Insider Financial, Simply Wall St, Dividend Investor, Wallet Investor, All Stocks, InvestorsHub and Stockhouse reported earlier on Sunshine Biopharma, Inc. (SBFM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sunshine Biopharma, Inc. is a pharmaceutical company listed on the OTC Markets. The Company concentrates on the development of drugs for the treatment of aggressive types of cancer. Furthermore, Sunshine offers generic pharmaceuticals, Essential Brand dietary supplements, and certified analytical chemistry services. Sunshine Biopharma has its corporate office in Pointe-Claire, Quebec.
The Company operates by way of three subsidiaries. These comprise Atlas Pharma, Inc. (Testing Services); Sunshine Biopharma Canada, Inc. (Generic Drugs); and NOX Pharmaceuticals, Inc. (Propriety Drugs). Atlas Pharma offers certified testing services of pharmaceutical and other industrial samples. Generic drugs coming soon from Sunshine Biopharma Canada (not available in the U.S.) include SBI-Anastrozole for treatment of Breast Cancer; SBI-Letrozole for treatment of Breast Cancer; SBI-Bicalutamide for treatment of Prostate Cancer; and SBI-Finasteride for treatment of BPH (Benign Prostatic Hyperplasia).
Regarding Sunshine Biopharma’s Proprietary Drugs in development, the Company’s flagship anticancer drug is Adva-27a. This is a GEM-difluorinated C-glycoside derivative of Podophyllotoxin, targeted for different kinds of cancer. The expectation is that Adva-27a will enter Phase I clinical trials for pancreatic cancer and multidrug resistant breast following completion of the GMP manufacturing and formulation of a 2-kilograms quantity for injection.
Sunshine Biopharma also has its dietary supplements product line - Essential 9™. This product contains all 9 essential amino acids in one tablet for maintaining and building muscle mass. In December of 2018, Sunshine Biopharma completed the development of Essential 9™. On December 14, 2018, Health Canada issued NPN 80089663 through which it authorized the Company to manufacture and sell the Essential 9™ product.
In December 2018, Sunshine Biopharma announced it signed an agreement with Crocus Laboratories Inc., (Montreal) for assistance in the manufacturing of Adva-27a. Crocus will help Sunshine Biopharma in the development of a large-scale process for the manufacturing of 2 to 5 kilograms of Adva-27a. The material, which will ultimately be generated by a contract manufacturing organization, will be used for animal toxicity studies and clinical trials.
Recently, Sunshine Biopharma announced it launched 7 new dietary supplements in addition to its original product, Essential 9™. The new products are BCAA; L-Carnitine; L-Creatine; L-Glutamine; Vitaminax; Omega 3; and Vitamin B12.
Sunshine Biopharma, Inc. (SBFM), closed Tuesday's trading session at $0.004, up 33.3333%, on 110,000 volume with 3 trades. The average volume for the last 3 months is 431,429 and the stock's 52-week low/high is $0.002099999/$0.200000002.
Edgewater Wireless Systems, Inc. (KPIFF)
StockPulse, TalkMarkets, Stockhouse, Stockwatch, OTC Markets, Insider Tracking, Trading View, and MarketWatch reported earlier on Edgewater Wireless Systems, Inc. (KPIFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Edgewater Wireless Systems, Inc. focuses on Wi-Fi infrastructure with its patented WiFi3™ technology and Next Generation Access Points. The Company commercializes innovative wireless technologies for the service provider market. Edgewater Wireless is developing significantly improved Wi-Fi network performance across an array of industries and challenging environments with premier performance, high flexibility, as well as consummate security. OTCQB-listed, Edgewater Wireless Systems has its corporate office in Ottawa, Ontario.
Established in 1988 by Edgewater Computer Systems, the Company has a global distribution network. It has invested greater than $50 Million in the development of Edgewater Wireless Products. It has sales partners in the United Kingdom (UK), Brazil, Peru, Asia and the United States.
Edgewater Wireless is patented, standards-compliant Wi-Fi delivering numerous concurrent channels of transmit and receive on a single radio in 2.4GHz & 5GHz – called Wi-Fi Spectrum Slicing. MCSR powers the Company’s products. Edgewater Wireless WiFi3™ powered access point products enable innovative service providers to plan, build and deploy reliable, high-capacity services (such as VoWiFI) for high-density & data demand in any environment.
The Company delivers the highest channel density available on the contemporary market. It uses Edgewater Wireless patented technology that enables manifold channels on a single chip. Therefore, aggregate output on a single WiFi3™ powered AP will outperform traditional, single channel APs.
Recently, Edgewater Wireless Systems, in joint development with CableLabs®, announced the availability of Dual Channel Wi-Fi™ in public open source. Developed jointly by CableLabs and Edgewater Wireless Systems, code to support Dual Channel Wi-Fi™ has been released into the OpenWrt repository. CableLabs® is a non-profit innovation and R&D lab. It was founded by members of the cable television industry.
Dual Channel Wi-Fi enables one or more downlink-only data channels in addition to a standard bi-directional channel. It is compatible with all Wi-Fi releases, including Edgewater’s MCSR™. Dual Channel Wi-Fi unlocks unused spectrum to significantly lessen contention and latency while increasing airtime utilization.
Edgewater Wireless Systems, Inc. (KPIFF), closed Tuesday's trading session at $0.063, off by 13.3425%, on 103,100 volume with 4 trades. The average volume for the last 3 months is 22,758 and the stock's 52-week low/high is $0.052499998/$0.163900002.
Fission Uranium Corp. (FCUUF)
Wealth Daily, Stock News Now, Metals News, Resource Stock Digest, TipRanks, Junior Mining Network, Energy and Capital, Streetwise Reports, Wallet Investor, Resource World, Stockhouse, and Zacks reported previously on Fission Uranium Corp. (FCUUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Fission Uranium Corp. engages in the exploration and development of uranium properties. The Company owns the award-winning PLS (Patterson Lake South) uranium project, host to the near-surface, high-grade Triple R deposit - part of the largest mineralized trend in the Athabasca Basin region. Significant new high-grade zones have been discovered each year since discovery in 2012. Recently, exploration drilling encountered mineralization 600m west of the trend. Fission Uranium is based in Kelowna, British Columbia and the Company lists on the OTC Markets’ OTCQX.
Fission Uranium is focusing on continued exploration at the large and highly-prospective PLS project and further development of the Triple R deposit. Patterson Lake South (PLS) is host to the aforementioned Triple R deposit - the most significant high grade shallow depth deposit in the area. The Triple R deposit is open in multiple directions, especially westwards, towards the high-grade boulder field. A preliminary economic study conducted in 2015 shows the Triple R has the potential for an OPEX of $14.02/lb. This would make it one of the world's lowest cost uranium producers.
Fission Uranium has 100 percent ownership of the PLS Property. The Property consists of 17 mineral claims totaling 31,039 ha situated on the southwest margin of the Athabasca Basin. The property is accessible by all-weather Highway 955 that continues north through the area of the UEX-AREVA Shea Creek deposits to the past producing Cluff Lake uranium mine.
This past March, Fission Uranium announced results from three holes of the Winter work program at its PLS property. The three holes were drilled on the R780E zone with the dual-purpose of resource expansion and geotechnical testing of rock-mechanics for mine planning. All three intercepted high-grade mineralization that fit within, and expanded beyond the boundaries of the present modeled high-grade domain.
Results include hole PLS19-PW-09, which intercepted a 37.5m continuous zone of strong uranium mineralization with a near-continuous 3.72 m interval of >10,000 cps and a peak of 61,115 cps. Additionally, hole PLS19-PW-10 intercepted 47.5m total composite mineralization. This includes 3.98m of total composite >10,000 cps.
In late May, Fission Uranium announced it filed a technical report on the Triple R Deposit at its PLS project, pursuant to National Instrument 43-101 "Standards of Disclosure for Mineral Projects" (NI 43-101). This Report summarizes the Pre-Feasibility Study that highlights the strong economics and long-term potential of the Triple R deposit.
Mineral Reserves were estimated for the Project, based on a hybrid (underground plus open pit) approach to production at PLS. In addition, the Report recognizes the potential for an underground-only approach that was completed to PEA level and shows substantial advantages. This includes lower CAPEX and shorter construction time. Therefore, the Company is advancing this scenario to Prefeasibility Study stage.
Fission Uranium Corp. (FCUUF), closed Tuesday's trading session at $0.37, up 0.543478%, on 103,301 volume with 45 trades. The average volume for the last 3 months is 131,887 and the stock's 52-week low/high is $0.333700001/$0.584699988.
Real Goods Solar, Inc. (RGSE)
StockTwits, Zacks, Insider Tracking, Investors Observer, AIStockFinder, Barchart, GlobeNewswire, MacroTrends, Stockhouse, and Market Screener reported previously on Real Goods Solar, Inc. (RGSE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Real Goods Solar, Inc. (RGS Energy) is the exclusive global manufacturer of the POWERHOUSE™ Solar Shingle System. This is an innovative in-roof solar shingle using technology developed by The Dow Chemical Company. The design of POWERHOUSE solar shingles are to integrate with asphalt roofing products. The POWERHOUSE Solar Shingle is a pioneering new roofing tile product. It combines the performance and protection of a conventional asphalt roof with an integrated photovoltaic (PV) system that powers a home. OTCQX-listed, Real Goods Solar is based in Denver, Colorado.
This past March, RGS Energy (RGSE) announced that its Board of Directors determined on March 27, 2019 to exit its mainland residential solar business to concentrate on the POWERHOUSE™ in-roof shingle market. By exiting the unprofitable mainland residential solar business, RGS Energy will lessen its overall cash outflow with the aim of maximizing future shareholder value. It is concentrating its efforts and resources on what it believes is a major opportunity with its POWERHOUSE™ solar shingle. This is because of the State of California’s mandate that all new homes built in 2020 include a solar installation.
RGSE believes the POWERHOUSE™ solar shingle has compelling competitive advantages. These include an aesthetically appealing low profile, with power efficiency and cost competitive to traditional rack-n-mount solar.
The POWERHOUSE 3.0 Solar Shingles operate as a roof and solar product. It is installed directly onto the roof deck along with standard asphalt roofing shingles. The design of POWERHOUSE 3.0 is to attain a competitive price point for Roofers; Homebuilders; Homeowners; and Solar Installers.
RGSE will hold a business update call on Tuesday, July 16, 2019 at 4:30 p.m. Eastern time to discuss POWERHOUSE. Before the start of the call, the Company will post a business update for the 30-day period since its last conference call on the investor relations section of its website.
Real Goods Solar, Inc. (RGSE), closed Tuesday's trading session at $0.295, up 3.5088%, on 569,717 volume with 135 trades. The average volume for the last 3 months is 2,016,845 and the stock's 52-week low/high is $0.064000003/$0.884000003.
Repro Med Systems, Inc. (REPR)
Zacks, Business Wire, Equity Clock, Dividend Investor, Marketbeat, Streetwise Reports, Market Screener, Wallmine, InvestorsHub, Wallet Investor, Simply Wall St, Infront Analytics, Stockwatch, Capital Cube, and Stockhouse reported earlier on Repro Med Systems, Inc. (REPR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Repro Med Systems, Inc. does business as RMS Medical Products (REPR) (RMS Medical). RMS Medical develops, manufactures and commercializes unique and user-friendly specialty infusion solutions, which improve quality of life for patients around the world. The Company has its FREEDOM Syringe Infusion System. Repro Med Systems is headquartered in Chester, New York. The Company lists on the OTC Markets Group’s OTCQX.
At present, the FREEDOM Syringe Infusion System includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. Repro Med Systems sells its products via direct sales and medical device distributors, and also online.
In April of this year, the Company that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HIgh-Flo Super26™ Subcutaneous Needle Sets (Super 26 Needle Sets). The Super26 Needle Sets are indicated for subcutaneous infusion of medications in the home, hospital, or ambulatory settings to facilitate high flow rates. This includes human plasma-derived immunoglobulins such as Hizentra® and Cuvitru™.
This month, Repro Med Systems, Inc., dba RMS Medical Products. announced the appointment of Mr. Craig S. Ross as Vice President of Sales and Marketing, effective July 1, 2019. Mr. Ross brings to RMS Medical close to 25 years of healthcare industry sales, marketing and leadership experience. This includes greater than two decades of combined experience at Baxalta US, Coram/CVS Specialty Infusion Services, and Schering-Plough. Mr. Ross’s background includes IV therapies, specialty care, biotechnology, pharmaceuticals, nutrition, supply chain, and healthcare transportation.
Today, Repro Med Systems, Inc., dba RMS Medical Products, announced that on June 28, 2019 the United States District Judge for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) issued a Final Judgment in favor of RMS Medical in the Company’s earlier announced litigation with EMED Technologies before that court. The District Judge adopted the decision of the Magistrate Judge that was issued on June 24, 2019, overruled EMED’s objections, awarded court costs to RMS Medical, and dismissed the case. The case was one of a number pending between RMS Medical and EMED.
Repro Med Systems, Inc. (REPR), closed Tuesday's trading session at $3.06, up 2.6846%, on 199,267 volume with 115 trades. The average volume for the last 3 months is 40,514 and the stock's 52-week low/high is $1.17999994/$3.05999994.
Spearmint Resources, Inc. (SPMTF)
Investing News, Investorx, MarketSmart Resources, Morningstar, Geology for Investors, Wallet Investor, Stockhouse, MarketWatch, Trading View, InvestmentPitch, 4-Traders, Stockwatch, Dividend Investor, and Junior Mining Network reported earlier on Spearmint Resources, Inc. (SPMTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
An exploration stage enterprise, Spearmint Resources, Inc. acquires, explores, and evaluates mineral properties in the U.S. and Canada. Its emphasis is on assembling a portfolio of low risk, high reward properties at the exploration stage and developing them to maximize shareholder value. The Company previously went by the name Indefinitely Capital Corp. It changed its name to Spearmint Resources, Inc. in February of 2012. OTC Markets-listed, Spearmint Resources is based in Vancouver, British Columbia (BC).
The Company’s current projects include a portfolio of prospects in the Golden Triangle of BC; the 'Golden Triangle Gold Prospects' consisting of six claims comprising 9,157 acres bordering GT Gold Corp, the 920 acre 'NEBA West' & 6,803 acre 'NEBA' Gold-Copper Prospects bordering Aben Resources Ltd, the 'Henry' Gold-Copper Prospect comprised of two contiguous claim blocks totaling 4,912 acres in the direct vicinity of Golden Ridge Resources Ltd., and the 17,593 acre 'EL North' Nickel-Copper Prospect comprising six contiguous claims in the Eskay Creek Camp bordering Garibaldi Resources Corp.
Its other BC projects include the 'Gold Mountain Prospects' consisting of three separate claim blocks totaling 1,245 acres bordering Barkerville Gold Mines, the 'Safari' Copper-Gold Prospect comprising 9,007 contiguous acres in the northern Quesnel Trough in north-central BC directly bordering Serengeti Resources Inc. and the 'Hammernose' Gold Prospect comprising 5,140 acres directly bordering the strategic alliance between Westhaven Ventures Inc. & Sable Resources Ltd. in the Spences Bridge Gold Belt in Southern BC.
Additionally, current projects include the 'Chibougamau Vanadium Prospects' consisting of 17,142 contiguous acres bordering the vanadium deposit of BlackRock Metal's (private) Ilmenite vanadium project and Vanadium One Energy Corp. and Spearmint's 'Clayton Valley Lithium Prospects' in Nevada comprising two claim blocks totaling 1,160 acres bordering Pure Energy Minerals & Cypress Development Corp. where Spearmint's drill results have intersected Lithium values as high as 1,670 ppm Li.
This past April, Spearmint Resources announced that it acquired the 'El North 3' claims package. The new acreage will result in a contiguous land package totalling 17,593 acres bordering Garibaldi Resources Corp. in the Golden Triangle of BC. Last week, Spearmint Resources announced the start of a work program on its "Golden Triangle Gold Prospects" and the start of a work program on its "NEBA" gold-copper prospect.
Spearmint Resources, Inc. (SPMTF), closed Tuesday's trading session at $0.0241, even for the day, on 35,000 volume. The average volume for the last 3 months is 24,270 and the stock's 52-week low/high is $0.000099999/$0.075699999.
Cannabis Sativa, Inc. (CBDS)
Promotion Stock Secrets, Top Pros’ Top Picks, smartOTC, Stockgoodies, Insider Financial, Wall Street Mover, Flagler Financial Group, Real Pennies, Marketbeat, TopStockAnalysts, TheMicrocapNews, Stock Beast, Jason Bond, TopPennyStockMovers, Cannabis Financial Network News, and Greenbackers reported earlier on Cannabis Sativa, Inc. (CBDS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cannabis Sativa, Inc. engages in branding and licensing via its 'hi' intellectual properties. The Company engages, by way of its subsidiaries, Wild Earth Naturals and "hi" Brands International, Inc., in the research, development, and licensing of specialized natural products. These include formulas, edibles, topicals, recipes, as well as delivery systems. Cannabis Sativa has been active in pursuing Intellectual Property (IP). It has successfully acquired an increasing portfolio of IP. OTCQB-listed, Cannabis Sativa has its corporate office in Mesquite, Nevada.
Cannabis Sativa brands, licenses, innovates, and markets first-rate plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and legal nutraceuticals and branded merchandise for consumers in general. The Company holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis. Moreover, it owns patent pending and trade secret formulas and processes.
hi Brands International entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Their CBD capsules are marketed under the name, "hi CBD." Cannabis Sativa has its Wild Earth Naturals offerings. It offers the Wild Earth Naturals line of CBD Water and cosmetic products designed to use organic and natural ingredients. These include CBD and hemp seed oil.
Cannabis Sativa entered into a license agreement for the manufacture, marketing, and sale of its White Rabbit products in California. It closed its acquisition of the White Rabbit brand of cannabis sprays and cannabis mints.
Furthermore, Cannabis Sativa acquired a controlling interest in PrestoCorp (a.k.a. PrestoDoctor). This online telemedicine platform provides access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology.
Cannabis Sativa also acquired a majority ownership interest in iBudtender, Inc., a Colorado corporation. It also entered into an agreement to acquire a 49 percent ownership interest in a nine-acre property in Los Angeles County, California. The ownership group’s intention is to lease the property to an industrial hemp farm operator.
Recently, Cannabis Sativa announced that on October 23, 2018, the United States Patent Office (USPTO) issued to the Company US Patent number 10105343 titled “Cannabis based compositions and methods of treating hypertension.” The marijuana lozenge invention relates to a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery consisting of a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plant Cannabis sativa, subspecies sativa and Cannabis sativa, subspecies indica of the CTSX-ISS lineage.
Mr. David Tobias, President, said, “CBDS acquired the rights to certain pending IP in a stock based, multimillion dollar agreement in 2014. Cannabis Sativa envisioned substantial value in the pending intellectual property which now granted, gives Cannabis Sativa the opportunity to standardize a marijuana product as well as a marijuana strain and position itself firmly in the marketplace.”
Cannabis Sativa, Inc. (CBDS), closed Tuesday's trading session at $1.93, up 28.6667%, on 270,078 volume with 561 trades. The average volume for the last 3 months is 66,962 and the stock's 52-week low/high is $1.22500002/$8.50.
Mobetize Corp. (MPAY)
Stockrow, Penny Stock Hub, Marketwired, MarketWatch, Investing Online, YCharts, GuruFocus, SmallCapVoice, Stockhouse, Street Insider, InvestorsHub, Market Screener, Capital Cube, Wallet Investor, Investors Hangout, Simply Wall St, and StockInvest.us reported earlier on Mobetize Corp. (MPAY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Mobetize Corp. is a provider of mobile financial services (MFS) technology for the multi-billion-dollar Business to Business (B2B) segment of the Fintech as a Service (FaaS) sector. The Company has developed a global B2B Fintech as a Service (FaaS) Supermarket. Mobetize has offices in Blaine, Washington; Reno, Nevada; and Vancouver, British Columbia. Mobetize lists on the OTC Markets Group’s OTCQB.
Mobetize digitizes bricks and mortar financial services to deliver mobile money services to leading telecommunications companies and financial institutions. The Mobetize technology helps the telecom and banking industries boost their revenues, reduce customer service costs, and increase loyalty to existing offerings.
The Company ensures end-to-end integration for services. This includes prepaid air-time top ups, data gifting, mobile lending, international money transfers, P2P transfers, Visa™/MasterCard™ programs and mobile bill payments. Mobetize seamlessly integrates and white labels its secure mobile money platform for its customers who subsequently offer the services to millions of users.
Concerning Mobetize for Telecom Operators, the Company has its smartBill, smartRemit, smartWallet, smartCharge, and smartF/X. The Company’s lending solutions include smartLoan and smartMortgage.
The Mobetize smartCard is a prepaid Visa or MasterCard debit card tied to a person’s smartWallet for online and retail point-of-sale (POS) purchases. The Company says that its Mobetize smartLoan is the fastest and most cost-effective route for financial institutions to deploy digitized consumer lending.
In October, Mobetize announced a partnership with Xpress Money in a FinTech collaboration founded on its smartRemit solution. smartRemit has been licensed by FICANEX® to launch its first-rate service SendGlobal™ with their member financial institutions. smartRemit is a proprietary white-label payments solution. It enables worldwide money transfer capabilities internationally.
smartRemit is totally integrated with the Xpress Money remittance processing network to provide convenient, efficient, scalable, and inexpensive international money transfers for senders and recipients using mobile devices. The design of smartRemit is to meet international compliance and security requirements drawing on Xpress Money’s considerable experience in global money remittance.
Mobetize Corp. (MPAY), closed Tuesday's trading session at $0.47965, up 2,298.25%, on 280 volume with 2 trades. The average volume for the last 3 months is 863,353 and the stock's 52-week low/high is $0.010999999/$1.85000002.
Viking Energy Group, Inc. (VKIN)
Daily Stock Motion, Penny Pick Insider, Penny Stocks VIP, Wall Street Beauties, FatCat Stocks, SmallCapFinancialWire, WINNINGOTC, SMS Penny Picks, Greenbackers, and Undiscovered Equities reported on Viking Energy Group, Inc. (VKIN), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Viking Energy Group, Inc. is an independent exploration and production corporation headquartered in New York, New York. The Company targets under-valued assets with realistic appreciation potential. Viking Energy owns oil and gas leases in Kansas, Missouri, Texas, Louisiana, Mississippi and Alberta. In essence, Viking purchases interests in producing, long-life, low-cost oil properties producing positive cash-flow. It is not considering speculative exploration programs. The Company previously went by the name Viking Investments Group, Inc. It changed its name to Viking Energy Group, Inc. in March of 2017.
Viking centers on acquiring under-valued, producing properties from distressed vendors or those considered as non-core assets by larger sector participants. The Company targets properties with present production and untapped reserves for future benefit. In Missouri, it owns a 100 percent W1 (roughly NRI 83 percent) in 31 leases, with access to the mineral rights (oil and gas) concerning about 5,500 acres of property in Cass and Bates Counties.
In Alberta, Viking Energy has a Joint Venture (JV) with Tanager Energy, Inc. Its investment with Tanager Energy includes a 50 percent WI in the Joffre Project, comprising 4 oil wells and one water injection well. Tanager Energy’s initial project incorporates the Leduc D-3 B Pinnacle Reef in Central Alberta where the Joffre D-3 Oil Project is positioned (the Joffre Project).
Viking Energy has acquired additional working interests in an assortment of oil and gas-related leases in Eastern Kansas. On September 11, 2017, Viking, by way of a wholly-owned subsidiary, Mid-Con Drilling, LLC, acquired a 90 percent WI in four new oil and gas leases in Anderson County in Eastern Kansas, comprising roughly 980 acres of property.
Viking, via its wholly-owned subsidiary, Mid-Con Petroleum, LLC, owns a working interest in 7 producing oil leases with access to the mineral rights (oil and gas) regarding roughly 800 acres of property in Miami and Franklin Counties in Eastern Kansas. Its working interests (WI’s) in the leases range from 68 percent to 100 percent.
Viking Energy Group has acquired, via its wholly-owned subsidiary, Mid-Con Development, a majority WI in a number of oil leases in Ellis and Rooks Counties in Kansas. Features of the acquired assets include more than 40 oil leases, consisting of roughly 3,300 acres.
Recently, Viking Energy Group announced that it filed a “Notice of Intention to Drill” regarding the proposed drilling of 21 new wells in Kansas. The Notices were filed with the Kansas Corporation Commission, Oil & Gas Conservation Division (the KCC), by S&B Operating, LLC on behalf of Mid-Con Drilling, LLC, one of Viking Energy’s wholly-owned subsidiaries, and relate to the proposed drilling of a combination of producing wells (oil) and water injection wells on certain of Mid-Con’s leases in the Counties of Douglas, Franklin, Miami and Allen in Eastern Kansas.
Viking Energy Group, Inc. (VKIN), closed Tuesday's trading session at $0.24, up 20.00%, on 132,271 volume with 19 trades. The average volume for the last 3 months is 98,170 and the stock's 52-week low/high is $0.140100002/$0.419999986.
Grow Solutions Holdings, Inc. (GRSO)
OTCtipReporter, StockRockandRoll, ResearchOTC, Elite Stock Alerts, Journal Transcript, Profitable Trader Authority, Stockgoodies, PennyStockScholar, and PennyStockLocks.com reported earlier on Grow Solutions Holdings, Inc. (GRSO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Grow Solutions Holdings, Inc. provides total support services in the broad area of high-yield indoor agriculture. The Company specializes in, but is not limited to, the legal and regulated growing and processing of cannabis. Its mission is to be recognized as the world’s foremost authority in the indoor high-yield agriculture industry. Formed in 2014, Grow Solutions Holding’s is based in Denver, Colorado.
Fundamentally, Grow Solutions centers on the development/distribution of high-demand products and services for cultivation, processing, as well as consumption of cannabis. Its diversified platform of operations and services for the industry consists of its Growth Technologies division (products needed to grow cannabis in and outside), its Consumer Technologies division (products to process, store and consume cannabis), and its Digital Properties division (online properties, including a state-of-the-art employment platform).
Grow Solutions Holdings acquired (in May of 2015) Boulder, Colorado-based One Love Garden Supply. One Love is a full-service garden and grow store that Grow Solutions expanded to greater than 7,000 square feet of space.
Additionally, in September of 2015, Grow Solutions acquired HyGrow. This acquisition is to expand its gardening supplies and agricultural products business. This acquisition enabled the Company to expand into Denver and Pueblo, Colorado.
Grow Solutions has developed and launched FutureTech Products of Pompano, Florida. FutureTech develops products for the consumer market to sell in smoke shops, head shops, and dispensaries.
Grow Solutions also acquired Keys Organic and Hydroponic Supply (Keys) in Florida. This acquisition of Keys expands on Grow Solutions’ existing operations in the southeast via its Future Tech division through providing a strategic location for the entry of its One Love Garden Supply subsidiary into east coast markets.
Furthermore, Grow Solutions acquired Mile High Hydro. This is a full service online grow store. It offers an extensive line of gardening supply and agricultural products to growers throughout the nation. Grow Solutions also acquired West Coast Organic and Hydroponic Supply (WCO) in Boring, Oregon.
Grow Solutions’ retail sales division uses Company funds for the acquisition of retail stores. These are stores that have shown significant presence in strategic locations.
Concerning the Company’s distribution division, it will allocate Company funds towards the manufacturing of proprietary products, bulk purchasing of a variety of products and technologies, warehousing, and the distribution and wholesale of these products to Grow Solutions retailers serving the indoor high-yield agriculture industry.
Grow Solutions’ Services division comprises Management and Consulting, Financing, Licensing, and Real Estate. Pertaining to Real Estate, the Company will acquire real estate and master leases then lease the properties to professional growers in different aspects of the indoor high-yield agriculture industry.
Grow Solutions Holdings, Inc. (GRSO), closed Tuesday's trading session at $0.0073, up 10.6061%, on 3,785,382 volume with 46 trades. The average volume for the last 3 months is 777,125 and the stock's 52-week low/high is $0.002499999/$0.041499998.
Inspyr Therapeutics, Inc. (NSPX)
BUYINS.NET and Zacks reported earlier on Inspyr Therapeutics, Inc. (NSPX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Inspyr Therapeutics, Inc. is a clinical-stage biotechnology company based in Westlake Village, California. It is developing novel prodrug therapeutics for the treatment of cancer. Mipsagargin is its lead agent. Mipsagargin is in human clinical trials for patients’ with numerous different tumor types. Inspyr Therapeutics’ team has considerable pharmaceutical industry and scientific experience.
The Company lists on the OTC Markets Group’s OTCQB. It previously went by the name GenSpera, Inc. It changed its name to Inspyr Therapeutics, Inc. in August of 2016.
Mipsagargin (G-202) is a prodrug in human clinical trials for patients with hepatocellular carcinoma (HCC, or liver cancer), glioblastoma (GBM, or brain cancer) and prostate cancer. Mipsagargin has been studied in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer). It has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication.
Mipsagargin is now undergoing evaluation in an open-label, single-arm, Phase II clinical study in patients with glioblastoma (brain cancer). In addition, it is undergoing evaluation in two Phase II clinical pilot studies in patients with prostate and clear cell renal cancer.
Inspyr Therapeutics has started the second development program for Mipsagargin as part of a combination therapeutic approach. This new program centers on the treatment of gastric cancer.
Inspyr has started a preclinical study in gastric cancer PDX tumor models that express varying levels of PSMA, the target of Mipsagargin. In this initial study, Mipsagargin will undergo evaluation initially in combination with paclitaxel.
Inspyr Therapeutics is developing a novel technology platform. This platform combines a strong therapeutic (thapsigargin) with a patented prodrug delivery system that targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. This unique platform technology has the potential to work across a range of drugs that precisely target different cancers.
In October of 2017, Inspyr Therapeutics announced the start of a new investigator-sponsored preclinical study of its proprietary adenosine receptor modulator (ARM) based compounds. The preclinical study is led by Elizabeth Kang, M.D., of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This study will assess these compounds for the prevention of graft versus host disease (GvHD), a potential side effect of allogeneic stem cell transplants.
Inspyr Therapeutics, Inc. (NSPX), closed Tuesday's trading session at $0.004, up 17.6471%, on 172,165 volume with 5 trades. The average volume for the last 3 months is 870,999 and the stock's 52-week low/high is $0.002199999/$0.01305.
TimefireVR, Inc. (TFVR)
Barchart, Stockhouse, Marketwired, InvestorsHub, MarketWatch, and Street Register reported on TimefireVR, Inc. (TFVR), and today we report on the Company, here at the QualityStocks Daily Newsletter.
TimefireVR, Inc. is a software company with a virtual reality platform for immersive, interactive, as well as social experiential learning. The Company formed in early 2014 to develop a virtual reality application platform, Hypatia, built on pillars of social interaction, commerce, cultural immersion, and entertainment. Hypatia is a curated virtual reality destination metaverse of massive scale.
On September 14, 2016, EnergyTek Corp. announced that it merged with Timefire LLC. The Company subsequently changed its name to TimefireVR, Inc. A technology enterprise, TimefireVR is headquartered in Scottsdale, Arizona.
Hypatia is influenced from some of the most visited cities in the world. TimefireVR's VR platform application provides an environment for cooperative participation and experiential learning in a safe environment.
With Hypatia, one can socialize, talking via text or audio. One can also shop; watch videos, concerts, and plays. With Hypatia, a user can create and customize the world about them. Additionally, a user can travel to real cities and fantasy destinations.
In June of 2017, TimefireVR formally launched its exclusive Virtual Reality title Hypatia, its multi-player multi-hour social environment.
However, last month, TimefireVR announced shifting its main corporate emphasis towards the strategic investments in crypto currency and potential acquisitions of blockchain technology businesses. As part of the shift in strategic direction, it sold its virtual reality assets. In addition, it appointed Mr. Jonathan Read to serve as Chief Executive Officer (CEO), Secretary, and Treasurer of TimefireVR.
Mr. Read has been a Director of TimefireVR since August 18, 2017. Since July 14, 2017, he has served as a member of the Board of Directors of BTCS, Inc. (BTCS), a blockchain technology focused company.
Mr. Jonathan Read, TimefireVR’s CEO, said, “Blockchain technology and its application of crypto currencies is an amazing enabling technology paradigm that will have a profound and disruptive impact on a host of industries. I am incredibly proud of our accomplishments in virtual reality; however, the Board of Directors made a strategic decision, in the best interest of our shareholders, to leverage my experience in blockchain technology where I serve as a member of the Board of Directors of BTCS Inc. (OTC Pink:BTCS), our strategic business vision and our ability to access the capital markets immediately.”
TimefireVR announced the sale of its virtual reality assets, mainly the social media/education platform and virtual world “Hypatia” to a group of investors. This includes its original founders, Mr. John Wise and Mr. Jeffrey Rassas. The expectation is that Hypatia will be a VR destination content leader. Consistent with this sale, TimefireVR expects to change its name following Board and shareholder approval.
At first, TimefireVR will concentrate on Ethereum, which is a foremost blockchain platform for Decentralized Applications (DApps). These are applications that run on a peer-to-peer network of computers instead of on one single computer or server.
TimefireVR, Inc. (TFVR), closed Tuesday's trading session at $0.0041, up 28.125%, on 157,000 volume with 6 trades. The average volume for the last 3 months is 1,240,369 and the stock's 52-week low/high is $0.001/$0.008.
Innovative Designs, Inc. (IVDN)
Greenbackers, Pennybuster, and PennyStocks24 reported earlier on Innovative Designs, Inc. (IVDN), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Innovative Designs, Inc. manufactures Insultex® House Wrap, the Arctic Armor® Line, hunting apparel, swimwear, wind shirts, jackets, and the multi-function "All in One" under the "IDI Gear" label featuring Insultex®. All of its products contain Insultex®. The Company’s products deliver premier warmth and comfort with insulating, windproof, as well as waterproof protection. Insultex® is the lightest and thinnest thermal insulation. Established in 2002, Innovative Designs is based in Pittsburgh, Pennsylvania.
Since its establishment, Innovative Designs has centered its efforts on completing the development, design, and prototypes of its products, and obtaining retail stores or sales agents to offer and sell its products. The Company primarily sells its products via agencies, distributors, independent sales agents, retailers, and a Website in the United States and Canada.
Additionally, the Company has concentrated its efforts on developing its website to sell more of its products, and on establishing distribution channels for its House Wrap® product.
Arctic Armor™ by IDI Gear is a 100 percent waterproof and windproof breathable nylon shell with Insultex® Thermal Insulation. The Company offers the Arctic Armor™ Suit. Each Arctic Armor™ suit uses three layers of its exclusive thermal insulator Insultex®. Moreover, Innovative Designs offers the Arctic Armor™ Ice Fishing Suit. The Company can also supply national home builders with its Insultex® House Wrap.
An example of Innovative Designs’ clothing products is its “Arctic Armor Extreme Cold Base Layer Shirt”. This shirt is 68.5 percent Thermo Cool Polyester and 31.5 percent Bamboo Charcoal. It is highly breathable and the wicking yarn keeps one comfortable and dry. It is ion-treated to promote oxygen uptake. It is also UV stable, and anti-static. The shirt also has anti-microbial technology to control odor.
Insultex® is the newest thermal insulation on the market. The material can be used in outerwear, gloves, hats, pants, tents, sleeping bags, coolers, boots, swimsuits, blankets, comforters, and other items.
Insultex® incorporates countless micro air cells. These individual pockets trap air and do not allow it to escape. This is the key to keeping people warm. Insultex® directly reflects the body’s radiant heat back to the body. Insultex® is windproof, waterproof, and buoyant.
This past June, Innovative Designs announced that it entered into a sales agreement with New Thinking Fashion USA, Inc. New Thinking Fashion USA specializes in the sale of finished fabrics to a broad assortment of apparel manufacturers. It will present Insultex™ to several of their present clients. New Thinking Fashion USA is a multilevel selling organization in the heart of the garment district on West 38th Street, New York, New York.
Also in June, Innovative Designs, in an attempt to grow its worldwide business, entered into a 2 year agreement with Epoch Consultants LLC, who has been granted exclusive rights in India. Epoch Consultants will be conducting marketing of Insultex™ to apparel manufacturers and the Indian military.
Innovative Designs, Inc. (IVDN), closed Tuesday's trading session at $0.198, up 98.00%, on 18,718 volume with 8 trades. The average volume for the last 3 months is 7,966 and the stock's 52-week low/high is $0.0271/$0.398000001.
The QualityStocks Company Corner
- MustGrow Biologics Corp.
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
- Earth Science Tech, Inc. (ETST)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Geyser Brands Inc. (TSX.V: GYSR)
- City View Green Holdings Inc. (CSE: CVGR)
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
- Willow Biosciences Inc. (CSE: WLLW)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4)
- Spectrum Global Solutions, Inc. (SGSI)
- Endonovo Therapeutics Inc. (ENDV)
- SinglePoint, Inc. (SING)
MustGrow Biologics Corp.
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
MustGrow Biologics, an agricultural biotech company, on Monday announced its receipt of approval from the Canadian Securities Exchange (“CSE”) for the listing of its common shares. According to the update, the company’s common shares will commence trading on the CSE at market open on Wednesday, July 10, 2019, under the ticker symbol “MGRO”. MustGrow’s signature, patented products are derived from mustard seed, utilizing its natural defense mechanism as a pre-plant soil biopesticide. The company is, in addition to its signature biopesticides, compiling a science-based suite of biological products, assessing potential product labels from third parties. Full details about MustGrow are included in the company’s final prospectus, with a copy available under its SEDAR profile. To view the full press release, visit http://ibn.fm/HjCG4.
MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
- MustGrow Biologics Corp. to Commence Trading on the CSE at Market Open on July 10
- QualityStocksNewsBreaks – MustGrow Biologics Corp. Providing Farmers with a Natural Alternative to Synthetic Pesticides, Fertilizers
- MustGrow Biologics Corp. Building Suite of Natural Biologic Agriculture Products to Protect Global Cannabis, Fruit & Vegetable Crops
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) received an amendment to its Health Canada license permitting the sale of cannabis oils from its Mississauga, Ontario facility. Sales of TerrAscend's cannabis oils are set to commence immediately through its medical marketplace, Solace Health. To view the full press releases, visit: http://nnw.fm/la1YD and http://nnw.fm/Vfk9L.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (TSX.V: RIV), closed Tuesday's trading session at $2.63, even for the day, on 229,503 volume with 666 trades. The average volume for the last 3 months is 109,888 and the stock's 52-week low/high is $1.75/$7.30155992.
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Key Health Canada License Amendments for Two Portfolio Companies
- Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
- CBD Retail Boom Expands with The Kroger Co.
Earth Science Tech, Inc. (ETST)
Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices and research and development. Headquartered in Doral, Florida, the company offers CBD in the form of vitamins, minerals, herbs, botanicals, personal-care products, homeopathies, functional foods and other products. An inventive biotech enterprise, ETST provides high purity and quality full-spectrum hemp CBD oil to the booming CBD market.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed Tuesday's trading session at $0.82, up 2.50%, on 108,121 volume with 82 trades. The average volume for the last 3 months is 54,161 and the stock's 52-week low/high is $0.300999999/$2.45000004.
- Earth Science Tech Inc. (ETST) Innovating as Worldwide Leader in CBD Space
- Earth Science Tech Inc. (ETST) Builds a Niche in Expansive Wellness Industry with Women’s Health, CBD Products
- Earth Science Tech Inc. (ETST) Subsidiaries Drive Prominent Placement in CBD Sector
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is getting its cannabis-based wellness products into an expanding number of consumers’ hands through retail partnerships that are not only extending the wholesome lifestyle brand’s reach but its mainstream market exposure as well.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Tuesday's trading session at $0.459, up 2.00%, on 9,245 volume with 16 trades. The average volume for the last 3 months is 21,811 and the stock's 52-week low/high is $0.009999999/$1.12999999.
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Expands Consumer Access with Retail Partnerships for CBD Product Lines
- Buzzfeed.com Features Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) Disposable Vaporizers, Aches and Immunity
- Wildflower Brands Announces the Closing of its Acquisition of City Cannabis and Satisfaction of Escrow Release Conditions
Geyser Brands Inc. (TSX.V: GYSR)
Consumer wellness brand cultivator Geyser Brands Inc. (TSX.V: GYSR) is moving forward with its vision of developing premier cannabis-enhanced products following Health Canada’s announcement that the company’s wholly owned subsidiary, Apothecary Botanicals (0957102 B.C. Ltd.), has been awarded a coveted standard processing license.
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Tuesday's trading session at $0.55, even for the day, on 2,000 volume. The average volume for the last 3 months is 8,507 and the stock's 52-week low/high is $0.33/$0.850000023.
- Geyser Brands Inc. (TSX.V: GYSR) Reaches Milestone in CBD Wellness Market with Reception of Processing License
- With NanoFusion, Geyser Addresses Challenge to Extract-Based Producers -- CFN Media
- 420 with CNW – 4 Ways to Spot the Best CBD Products
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings Inc. (CSE: CVGR) is poised to benefit following Alberta’s AGLC regulatory agency’s decision to lift its moratorium on accepting new retail cannabis licenses, announcing that it will issue five new licenses weekly (http://nnw.fm/y6X62). CVGR sees the move as providing a direct route to market for its products, as Budd Hutt, the company’s retail arm, seeks strong financial investment partners and retail partnerships in Alberta and across Canada (http://nnw.fm/keEZ2).
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Tuesday's trading session at $0.55, even for the day, on 2,000 volume. The average volume for the last 3 months is 8,507 and the stock's 52-week low/high is $0.094999998/$0.465000003.
- City View Green Holdings Inc.’s (CSE: CVGR) Retail Arm Pursuing Retail Cannabis Partnerships
- City View Green Announces Proposed $3,000,000 Private Placement
- NetworkNewsBreaks – City View Green Holdings Inc. (CSE: CVGR) Building Diversified Cannabis Business
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc, a leading licensed producer of cannabis, on Monday announced that it has developed a proprietary nano-emulsification technology for the production of both liquid and powdered cannabinoid products in anticipation of Canada’s legalization of adult use recreational cannabis edibles and consumer demand for cannabis-infused beverages. To view the full press release, visit: http://nnw.fm/w1Zcd.
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $6.92, off by 2.2599%, on 2,383,495 volume with 9,362 trades. The average volume for the last 3 months is 919,960 and the stock's 52-week low/high is $2.97000002/$8.43999958.
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Development of Nano-Emulsification Technology for Liquid and Powdered Cannabis Products
- Organigram Announces Expanded Development of Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages
- Organigram Holdings Inc. to Report Third Quarter Fiscal 2019 Results on July 15, 2019
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Green Growth Brands Inc. (CSE: GGB; OTCQB: GGBXF) is pleased to announce that it has entered into a securities acquisition and contribution agreement (the Agreement), dated as of July 8, 2019, with, among others, MXY Holdings LLC (Moxie) under which a new Ontario limited partnership, of which GGB will be the general partner (GGB LP), will acquire the operating companies of GGB and the issued and outstanding units of Moxie, an arm’s length third party, in an all-equity interest transaction (the Transaction).
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $2.37, off by 2.8569%, on 1,205,333 volume with 1,740 trades. The average volume for the last 3 months is 330,025 and the stock's 52-week low/high is $1.8068/$5.20499992.
- Green Growth Brands to Create First '360 Degree' Cannabis Company Through a Combination with MXY Holdings LLC
- CBD Companies Quickly Expanding their Global Footprint
- Green Growth Brands Announces Expansion with Abercrombie & Fitch to Sell Seventh Sense CBD Products in over 160 Stores
Willow Biosciences Inc. (CSE: WLLW)
The sea change in societal attitudes about cannabis, accompanied by the opening of governmental regulatory doors for its use (http://nnw.fm/DpU6B), has spawned a land rush by corporate interests set on staking out market territory for business development (http://nnw.fm/x1Vrv). The so-called “green rush” began when chronically ill patients reported that cannabis properties provided accessible relief for select conditions. Now, InvestmentPitch Media is reporting in a new video that cannabis industry newcomer Willow Biosciences Inc. (CSE: WLLW) can deliver high yields of ultra-pure, low-cost cannabinoids to an evolving market utilizing proprietary biosynthetic processes.
Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.
The company is headquartered in Calgary, Alberta, Canada.
Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.
The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.
Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.
Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.
Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.
The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.
Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.
The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.
The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.
The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.
Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.
President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.
Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.
Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.
Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.
Willow Biosciences Inc. (CSE: WLLW), closed Tuesday's trading session at $0.98, off by 13.27%, on 29,998 volume with 38 trades. The average volume for the last 3 months is 48,919 and the stock's 52-week low/high is $0.980000019/$5.25.
- Video Outlines Benefits of Willow Biosciences Inc.’s (CSE: WLLW) JDA to Develop CBD through Biosynthesis
- 420 with CNW – Maine Recreational Marijuana Regulations Signed
- Willow Biosciences Inc. (CSE: WLLW) is “One to Watch”
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp (LXRP:OTCQX LXX:CSE), based in Kelowna, BC, focused on the improved delivery of active pharmaceutical ingredients in food, beverages and topicals, today announced that Chris Bunka, CEO will present live at VirtualInvestorConferences.com on July 11th. TIME: 12:30 PM ET, LINK: https://tinyurl.com/July11VICPR. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Contrary to the common perception that most people buy marijuana in order to get stoned, a new study done by the University of Miami and the Albert Einstein College of Medicine has found that the majority of those who buy marijuana in Colorado use the substance as a sleep aid. These findings are significant because recreational marijuana has been legal in the state for about 5 years now.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.
In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.7755, off by 5.9573%, on 173,811 volume with 100 trades. The average volume for the last 3 months is 82,664 and the stock's 52-week low/high is $0.75/$2.24.
- Lexaria Bioscience Corp to Webcast Live at VirtualInvestorConferences.com July 11th
- 420 with CNW – Study Finds Most People Buy Marijuana to Get Some Sleep
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Leading the Way in Effective Cannabis Treatment
Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4)
Redfund Capital Corp (CSE: LOAN) (Frankfurt:O3X4) (OTC: PNNRF) (Redfund or the “Company”) is pleased to announce that Wahupta Ventures’ 100% owned division, Curran Technologies, has signed their first USA extraction system order with Health Care Industries, worth $670,000. Health Care Industries of Marco Island, Florida, has secured for one of their divisions Curran Technologies’ first USA purchase order.
Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.
As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.
The central components of the company’s business strategy are:
- Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
- Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.
Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.
Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.
The strategy employed by Redfund includes:
- Diversifying investments in Canada and other countries
- Building an international footprint with established national leaders
- Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
- Introducing companies to Canada as a viable option for public listings
- Becoming a premier go-to lender for established companies
The company’s revenue sources include:
- Interest-bearing debt instruments with asset-backed collateral to securitize loans
- Equity kicker of warrants coverage on original loan
- Conversion ability of loan in its entirety
- Advisory fees from contracts for consulting on growth strategies
- Right of first refusal on future financing in each company funded
Redfund Capital Corp. (OTCQB: PNNRF), closed Tuesday's trading session at $0.0887, off by 13.8835%, on 3,000 volume with 1 trade. The average volume for the last 3 months is 471 and the stock's 52-week low/high is $0.088699996/$0.504999995.
- Redfund Client Wahupta Signs First USA-Based Customer
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) Enters CBD Sector Through Equity Acquisition of Wahupta Ventures
- 420 with CNW – 2019 Federal Data Shows More Banks are Accepting Marijuana Businesses
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions (OTCQB: SGSI), a leading provider of telecommunications engineering and infrastructure services and solutions, is preparing to meet the increasing demand for 5G. An article discussing the company reads, “The company is ready for a 5G-networks rollout this year and is strategically positioned to meet the demand. Over the next five to seven years, according to Deloitte, up to $150 billion in fiber investment will be required in the United States (http://nnw.fm/1GDNp). To view the full article, visit: http://nnw.fm/9EcEs.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Tuesday's trading session at $0.05, off by 23.0769%, on 228,415 volume with 26 trades. The average volume for the last 3 months is 115,126 and the stock's 52-week low/high is $0.045000001/$2.5999999.
- Spectrum Global Solutions Inc. (SGSI) Strategically Positioned to Meet Growing 5G Demand
- Spectrum Global Solutions Inc. (SGSI) Primed to Benefit as 5G Deployments Create Jobs, Safer Cities and Organic Growth Opportunities
- NetworkNewsBreaks – Spectrum Global Solutions Inc.’s (SGSI) Bundled Services Approach Drives Growth
Endonovo Therapeutics Inc. (ENDV)
Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company, recently named Dr. Steven Levin, M.D., to its scientific advisory board. An article further discussing the appointment reads, “‘Dr. Levin’s vast experience with novel therapies in the anesthesiology and pain-management field, as well as his strong research interest to improve clinical practice in pain management, will be valuable scientific additions to Endonovo,’ Alan Collier, CEO of Endonovo Therapeutics, said in a news release (http://nnw.fm/PeF8s). To view the full article, visit: http://nnw.fm/zdN1H.
Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.
In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.
SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?
Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.
Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.
Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.
Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?
Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.
Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.
Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.
David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.
Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.
Endonovo Therapeutics Inc. (ENDV), closed Tuesday's trading session at $0.0165, off by 9.8361%, on 14,155,877 volume with 238 trades. The average volume for the last 3 months is 5,511,993 and the stock's 52-week low/high is $0.008999999/$0.066100001.
- Endonovo Therapeutics Inc. (ENDV) Adds National Leader to Scientific Advisory Board
- Endonovo Therapeutics Inc. (ENDV) Offers Non-Narcotic, Non-Invasive Power of SofPulse to Help Patients Recover More Quickly
- Endonovo Therapeutics Inc. (ENDV) Appoints National Leader in Pain Management to Scientific Advisory Board
SinglePoint, Inc. (SING)
SinglePoint, Inc. (SING) was highlighted today in a publication from Investorideas.com, examining how Fior Markets said in its recent report, 'the global industrial hemp market is expected to grow from USD 4.41 Billion in 2018 to USD 14.67 Billion by 2026'.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.0151, off by 2.297%, on 4,960,438 volume with 143 trades. The average volume for the last 3 months is 5,932,133 and the stock's 52-week low/high is $0.009999999/$0.0447.
- CBD/ Hemp Snapshot: Growing Demand is Game Changer for Sector - Driving Revenues and Acquisitions
- Direct Solar becomes Exclusive Solar Marketing Partner to Support Sport Programs for 47 Texas Schools
- SinglePoint Inc. (SING) Signs Contract to Supply $100 Million of Premium Hemp Flower
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) in Final Negotiations to Significantly Expand Cannabis Cultivation and Retail Operations
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Receives Key Licence Amendment from Health Canada
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – Colorado Governor Unveils Online Tool to Track Cannabis Achievements
- ChineseInvestors.com (CIIX) 420 with CNW – Colorado Governor Unveils Online Tool to Track Cannabis Achievements
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Surpasses $49,000 in Opening Day Sales at the Niagara Flagship Cannabis Store
- City View Green Holdings Inc. (CSE: CVGR) Announces Proposed $3,000,000 Private Placement
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Builds a Niche in Expansive Wellness Industry with Women’s Health, CBD Products
- Endonovo Therapeutics (OTCQB: ENDV) Offers Non-Narcotic, Non-Invasive Power of SofPulse to Help Patients Recover More Quickly
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Successfully Completes Technological Demonstrations for Leading Vehicle Manufacturers and Tier One Suppliers in United States
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- Geyser Brands Inc. (TSX.V: GYSR) With NanoFusion, Geyser Addresses Challenge to Extract-Based Producers -- CFN Media
- Golden Developing Solutions, Inc. (DVLP) Achieves Fully Reporting Status with SEC
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) CBD Companies Quickly Expanding their Global Footprint
- Green Hygienics Holdings Inc. (GRYN) Set to Benefit from New California Hemp Regulations Paving the Way for Widespread Cultivation
- Hemptown USA - The Cannabinoid of the Future? Hemptown USA at the Forefront of CBG’s Rise to Prominence
- INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Enters Agreement with Lifespot to Develop and Distribute Software and Vaporizer Technologies
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Leading the Way in Effective Cannabis Treatment
- Marijuana Company of America Inc. (MCOA) Announces Reverse Stock Split of Common Stock
- MustGrow Biologics Corp. - Providing Farmers with a Natural Alternative to Synthetic Pesticides, Fertilizers
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Closes Initial Share Purchase of Cannova Medical Ltd.
- Net Element, Inc. (NASDAQ: NETE) Adds Proprietary, AI-Powered Underwriting Solution to Suite of Offerings
- Nightfood, Inc. (OTCQB: NGTF) and All-World NFL Cornerback Richard Sherman Team Up to Launch Custom Ice Cream Flavor
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Expanded Development of Rapid-Onset Nano-Emulsification Technology for Cannabis Beverages
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Phase 2 Nickel-Cobalt Extraction Process Testing and Evaluation Commences
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Secures Licensing Contract for its CORT Oil Extraction Technology 6
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Dominates California Edibles Market
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at Spectrometry Conference
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Assay Results Suggest Further Tonnage at Irgon Property
- Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) Enters CBD Sector Through Equity Acquisition of Wahupta Ventures
- Sharing Services Global Corporation (SHRG) Business Entrepreneurship Model Drives Success in Booming Direct-Sales Market
- SinglePoint, Inc. (SING) Direct Solar becomes Exclusive Solar Marketing Partner to Support Sport Programs for 47 Texas Schools
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Carving out Niche in Burgeoning LTE Market Projected to Reach $997B by 2020
- Spectrum Global Solutions, Inc. (SGSI) Primed to Benefit as 5G Deployments Create Jobs, Safer Cities and Organic Growth Opportunities
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Readies for Canada’s Second Cannabis Wave with Successful Run of APP Extraction Process
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) 420 with CNW – 5 Trends Making a Mark on the Cannabis Industry in 2019
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) CBD Companies Quickly Expanding their Global Footprint
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Building Reputation as Leading Organic Cannabis Provider
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Enters Definitive Agreement to Acquire The GoodFellas Group LLC
- Trxade Group Inc. (TRXD) Web Platform Promises Reduced Negative Reimbursement Costs for Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Cannabis Edibles Could Cause a Spike in Life Insurance Premiums for Canadians
- VPR Brands, LP (VPRB) Launches New HRB Turbo Dry Herb Vaporizer
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Disposable Vaporizers, Aches and Immunity
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Maine Recreational Marijuana Regulations Signed
- Youngevity International, Inc. (NASDAQ: YGYI) Horizons ETFs Rebalances Marijuana-Focused ETFs
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.